We are live on
!
Find out more
First Manhattan Portfolio holdings
AUM
$36.1B
1-Year Est. Return
11.5%
This Fund
S&P 500
This Quarter
Est. Return
+12.39%
1 Year Est. Return
+11.5%
3 Year Est. Return
+74.65%
5 Year Est. Return
+103.66%
10 Year Est. Return
+354.63%
AUM
$19.4B
AUM Growth
+$2.11B
(+12%)
Cap. Flow
+$90.4M
Cap. Flow
% of AUM
0.47%
Top 10 Holdings %
Top 10 Hldgs %
53.93%
Holding
1,534
New
81
Increased
246
Reduced
456
Closed
138
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$105M |
| 2 |
Match Group
MTCH
|
+$77.8M |
| 3 |
NextEra Energy
NEE
|
+$64.3M |
| 4 |
Keysight
KEYS
|
+$62.4M |
| 5 |
AutoZone
AZO
|
+$56.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPLI
People Inc
PPLI
|
+$82.5M |
| 2 |
Microsoft
MSFT
|
+$42.5M |
| 3 |
Apple
AAPL
|
+$38.2M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$27M |
| 5 |
Johnson & Johnson
JNJ
|
+$22.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 38.9% |
| 2 | Technology | 17.9% |
| 3 | Healthcare | 11.08% |
| 4 | Communication Services | 8.12% |
| 5 | Consumer Discretionary | 7.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JBGS
401
JBG SMITH
JBGS
$846M
| $815K | ﹤0.01% |
30,516
-2,288
| -7% | -$64.2K |
|
402
GSK
GSK
$103B
| $814K | ﹤0.01% |
17,316
-609
| -3% | -$30.5K |
|
403
Vanguard Growth ETF
VUG
$216B
| $809K | ﹤0.01% |
21,348
+804
| +4% | +$29.7K |
|
404
Invesco DB Commodity Index Tracking Fund
DBC
$1.73B
| $807K | ﹤0.01% |
61,800
+15,300
| +33% | +$200K |
|
405
Sprott Physical Silver Trust
PSLV
$11.9B
| $805K | ﹤0.01% |
97,395
| – | – |
|
406
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$39.7B
| $794K | ﹤0.01% |
27,140
-6,700
| -20% | -$196K |
|
407
Mercury Insurance
MCY
$5.94B
| $765K | ﹤0.01% |
18,500
| – | – |
|
|
CNBKA
408
DELISTED
Century Bancorp Inc/Mass
CNBKA
| $762K | ﹤0.01% |
11,600
| – | – |
|
|
SAND
409
DELISTED
Sandstorm Gold
SAND
| $759K | ﹤0.01% |
90,000
| – | – |
|
410
Sonoco
SON
$5.76B
| $743K | ﹤0.01% |
14,555
+720
| +5% | +$38.1K |
|
411
Vanguard Value ETF
VTV
$189B
| $743K | ﹤0.01% |
7,112
+710
| +11% | +$74.4K |
|
412
Vanguard Small-Cap Value ETF
VBR
$37.1B
| $739K | ﹤0.01% |
6,687
| – | – |
|
413
Vanguard Russell 1000 Growth ETF
VONG
$42.5B
| $736K | ﹤0.01% |
13,220
-1,580
| -11% | -$85.6K |
|
|
HES
414
DELISTED
Hess
HES
| $735K | ﹤0.01% |
17,975
-581
| -3% | -$27.6K |
|
415
VanEck Gold Miners ETF
GDX
$23B
| $733K | ﹤0.01% |
18,727
+3,727
| +25% | +$152K |
|
416
Truist Financial
TFC
$63.2B
| $728K | ﹤0.01% |
19,135
+390
| +2% | +$14.7K |
|
417
W.P. Carey
WPC
$17.1B
| $714K | ﹤0.01% |
11,200
| – | – |
|
418
Schwab Emerging Markets Equity ETF
SCHE
$12.3B
| $713K | ﹤0.01% |
26,676
-5,475
| -17% | -$146K |
|
419
Medtronic
MDT
$107B
| $708K | ﹤0.01% |
6,817
-169
| -2% | -$17K |
|
|
BOCH
420
DELISTED
Bank of Commerce Holdings (CA)
BOCH
| $706K | ﹤0.01% |
101,400
+200
| +0.2% | +$1.48K |
|
421
Unilever
UL
$131B
| $704K | ﹤0.01% |
10,151
| – | – |
|
422
Lumen
LUMN
$6.53B
| $699K | ﹤0.01% |
69,369
-76
| -0.1% | -$790 |
|
423
Arrow Electronics
ARW
$10.9B
| $694K | ﹤0.01% |
8,833
| – | – |
|
424
VanEck Junior Gold Miners ETF
GDXJ
$7.06B
| $694K | ﹤0.01% |
12,550
+4,650
| +59% | +$268K |
|
425
Tootsie Roll Industries
TR
$2.82B
| $688K | ﹤0.01% |
26,592
-2,315
| -8% | -$61.8K |
|
Similar funds
SAM
First Manhattan's Q3 2020 Portfolio in Review
As of Q3 2020, First Manhattan held 1,534 positions worth $19.4B, up 12% from $17.3B the previous quarter. Its ten largest holdings account for 54% of the portfolio.
First Manhattan's Q3 2020 filing shows 81 new, 246 increased, 456 reduced and 138 closed positions. Its largest new stake was Constellation Pharmaceuticals, Inc.: 250,400 shares worth $5.07M. The largest sale was People Inc, an estimated $82.5M.
By sector, the portfolio is most concentrated in Financials at 39% of assets, up from 38% a quarter earlier, followed by Technology and Healthcare.
- First Manhattan's largest Q3 2020 buy was Constellation Pharmaceuticals, Inc.: 250,400 shares worth $5.07M.
- First Manhattan added most to UnitedHealth in Q3 2020, an estimated $105M increase.
- First Manhattan's biggest Q3 2020 reduction was People Inc, cutting an estimated $82.5M.
- First Manhattan fully exited Aimmune Therapeutics in Q3 2020, selling an estimated $17.1M.
- First Manhattan's ten largest holdings make up 54% of its $19.4B portfolio in Q3 2020.
- First Manhattan opened 81 new positions and closed 138 in Q3 2020.
- First Manhattan's portfolio value rose 12% quarter-over-quarter to $19.4B.
Based on First Manhattan's 13F filing for Q3 2020, filed 12 Nov 2020.